Hjem › Rhabdoid tumor › District of Columbia
Kliniske studier for Rhabdoid tumor i District of Columbia
5 studier for Rhabdoid tumor søker deltakere på steder i District of Columbia.
Byer i District of Columbia
Offisiell studietekst (engelsk)
NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors
- Children's National Hospital, Washington D.C.
RekruttererFase 1
Alder 3 til 25 · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07664176Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)
- Children's National Hospital, Washington D.C.
RekruttererFase 1
Alder 1 til 30 · Alle kjønn · Oppdatert 17. jun. 2026 · NCT06193759Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
- Children's National Medical Center, Washington D.C.
RekruttererFase 1/2
12 Months – 30 Years · Alle kjønn · Oppdatert 19. mai 2026 · NCT04901702A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
- Children's National Hospital (Data Collection Only), Washington D.C.
RekruttererFase 2
12 Months · Alle kjønn · Oppdatert 6. mai 2026 · NCT05985161A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Children's National Medical Center, Washington D.C.
RekruttererFase 2
18 Months – 40 Years · Alle kjønn · Oppdatert 12. aug. 2025 · NCT05135975Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.